Kimia Biosciences Ltd (NSE: KIMIABL), ISIN INE285U01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
KIMIABL last traded at ₹31.01 (-1.46%), with a 52-week range of ₹23.20 to ₹66.00 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 74.94%, FIIs 0.00%, DIIs 0.38%, mutual funds 0.38%.
EquiSense Score (ECS): 26/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.